60 related articles for article (PubMed ID: 8504987)
1. The proto-oncogene c-fms is overexpressed in endometrial cancer.
Leiserowitz GS; Harris SA; Subramaniam M; Keeney GL; Podratz KC; Spelsberg TC
Gynecol Oncol; 1993 May; 49(2):190-6. PubMed ID: 8504987
[TBL] [Abstract][Full Text] [Related]
2. Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue.
Nephew KP; Choi CM; Polek TC; McBride R; Bigsby RM; Khan SA; Husseinzadeh N
Gynecol Oncol; 2000 Mar; 76(3):388-96. PubMed ID: 10684716
[TBL] [Abstract][Full Text] [Related]
3. The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.
Smith HO; Anderson PS; Kuo DY; Goldberg GL; DeVictoria CL; Boocock CA; Jones JG; Runowicz CD; Stanley ER; Pollard JW
Clin Cancer Res; 1995 Mar; 1(3):313-25. PubMed ID: 9815987
[TBL] [Abstract][Full Text] [Related]
4. The relationship between point mutation and abnormal expression of c-fms oncogene in hepatocellular carcinoma.
Yang DH; Huang W; Cui J; Shu JC; Tang SH; Zhang WJ; Liang JH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):86-9. PubMed ID: 14969845
[TBL] [Abstract][Full Text] [Related]
5. FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.
Soufla G; Sifakis S; Spandidos DA
Cancer Lett; 2008 Feb; 259(2):146-55. PubMed ID: 18006148
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of M-CSF transcripts and protein, FMS (M-CSF receptor) transcripts and protein, and steroid receptor content in adenocarcinomas of the ovary.
Kommoss F; Wölfle J; Bauknecht T; Pfisterer J; Kiechle-Schwarz M; Pfleiderer A; Sauerbrei W; Kiehl R; Kacinski BM
J Pathol; 1994 Oct; 174(2):111-9. PubMed ID: 7965406
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
[TBL] [Abstract][Full Text] [Related]
8. Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas.
Foca C; Moses EK; Quinn MA; Rice GE
Gynecol Oncol; 2000 Nov; 79(2):244-50. PubMed ID: 11063652
[TBL] [Abstract][Full Text] [Related]
9. Colony-stimulating factor-1 and c-fms expression in human endometrial tissues and placenta during the menstrual cycle and early pregnancy.
Kauma SW; Aukerman SL; Eierman D; Turner T
J Clin Endocrinol Metab; 1991 Oct; 73(4):746-51. PubMed ID: 1832423
[TBL] [Abstract][Full Text] [Related]
10. Oestrogen regulated gene expression in normal and malignant endometrial tissue.
O'Toole SA; Dunn E; Sheppard BL; Sheils O; O'Leary JJ; Wuttke W; Seidlova-Wuttke D
Maturitas; 2005 Jun; 51(2):187-98. PubMed ID: 15917160
[TBL] [Abstract][Full Text] [Related]
11. Analysis of MDR1 expression in normal and malignant endometrium by reverse transcription-polymerase chain reaction and immunohistochemistry.
Kuo DY; Mallick S; Shen HJ; DeVictoria C; Jones J; Fields AL; Goldberg GL; Runowicz CD; Horwitz SB
Clin Cancer Res; 1996 Dec; 2(12):1981-92. PubMed ID: 9816157
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
[TBL] [Abstract][Full Text] [Related]
13. Effect of all-trans-retinoic acid on c-fms proto-oncogene [colony-stimulating factor 1 (CSF-1) receptor] expression and CSF-1-induced invasion and anchorage-independent growth of human breast carcinoma cells.
Sapi E; Flick MB; Tartaro K; Kim S; Rakhlin Y; Rodov S; Kacinski BM
Cancer Res; 1999 Nov; 59(21):5578-85. PubMed ID: 10554038
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of beta1 integrin expression in the physio/pathological states of human endometrial tissues.
Moro L; Greco M; Maiorano E; Selvaggi L; Marra E; Perlino E
Int J Oncol; 2005 Feb; 26(2):457-65. PubMed ID: 15645131
[TBL] [Abstract][Full Text] [Related]
15. An unexpected effect of glucocorticoids on stimulation of c-fms proto-oncogene expression in choriocarcinoma cells that express little glucocorticoid receptor.
Chambers SK; Ivins CM; Kacinski BM; Hochberg RB
Am J Obstet Gynecol; 2004 Apr; 190(4):974-85. PubMed ID: 15118624
[TBL] [Abstract][Full Text] [Related]
16. BAG-1 expression in normal and neoplastic endometrium.
Moriyama T; Littell RD; Debernardo R; Oliva E; Lynch MP; Rueda BR; Duska LR
Gynecol Oncol; 2004 Aug; 94(2):289-95. PubMed ID: 15297164
[TBL] [Abstract][Full Text] [Related]
17. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC
Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
[TBL] [Abstract][Full Text] [Related]
18. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
Vaskivuo TE; Stenbäck F; Tapanainen JS
Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated expression of CD66a (BGP, C-CAM), an adhesion molecule of the CEA family, in endometrial cancer.
Bamberger AM; Riethdorf L; Nollau P; Naumann M; Erdmann I; Götze J; Brümmer J; Schulte HM; Wagener C; Löning T
Am J Pathol; 1998 Jun; 152(6):1401-6. PubMed ID: 9626043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
